Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × alectinib × 1 year × Clear all

Phase

Status

Sponsor Class

INDUSTRY 13 OTHER 7 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 43 Magnetic Resonance Spectroscopy 35 Cyclophosphamide 31 Vincristine 25 Cisplatin 25 Radiation 23 Carboplatin 23 Radiotherapy 21 Etoposide 19 Dexamethasone 19 Doxorubicin 17 durvalumab 14 daratumumab 14 Radiotherapy, Intensity-Modulated 14 Paclitaxel 14 Biopsy 14 Platinum 12 Observation 12 Lenalidomide 12 Irinotecan 12 Fluorouracil 12 1,2-diaminocyclohexaneplatinum II citrate 12 Prednisone 11 Leucovorin 11 Docetaxel 11 Gemcitabine 10 Cytarabine 10 Bortezomib 10 fludarabine 9 Watchful Waiting 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03445000 2025-04-08

ALERT-lung

ETOP IBCSG Partners Foundation

Phase 2 Terminated

14 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡